Eli Lilly (LLY) plans to invest more than $1B in India in the coming years to boost manufacturing and supply through local drugmakers, Reuters’ Rishika Sadam reports. “We are making significant investments to increase manufacturing and medicine supply capacity around the world,” Patrik Jonsson, president of Lilly International, said, adding that India is a hub for capability building within its global network.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Eli Lilly’s Stock Soars Amid Promising Trials
- Alphabet, Micron, Block, Costco, Eli Lilly: Major Stock Moves Unveiled!
- Looking for Exposure to UnitedHealth Stock (UNH)? Here’s How to Buy Without the Risk
- Sector Spotlight: UnitedHealth shareholder proposes split of CEO, chair role
- Trump Weekly: White House announces drug pricing deal with Pfizer